A patient undergoes rehabilitation treatment through mental control using a brain-computer interface device at a hospital in Chongqing on April 10. CHEN CHENG/XINHUA

　　Inside a quiet rehabilitation ward in eastern China, a paralyzed patient stares intently at a plastic cup. He doesn't move a muscle, yet a robotic, pneumatic glove encasing his paralyzed hand suddenly hums to life, smoothly closing its fingers around the cup.

　　The invisible trigger? His sheer intention.

　　By decoding neural signals and bypassing severed spinal cords entirely, brain-computer interface (BCI) technology is performing what looks like medical magic. But behind this clinical breakthrough lies a rapidly maturing business ecosystem. Driven by a strategic influx of venture capital and robust policy tailwinds, BCI is fast graduating from academic curiosity to early commercial deployment.

　　For years, the BCI sector was a pure-play scientific endeavor confined to university labs. Today, it is arguably the hottest frontier in venture capital.

　　Data from a recent report by the Beijing-based Fourth Wave Technology Think Tank and Zhongguancun Tiancheng Innovation Research Center paint a staggering picture. Throughout 2025, Chinese BCI startups recorded at least 24 financing events, raising more than 1.45 billion yuan ($212.1 million). In stark contrast, the first three months of 2026 alone saw at least 17 funding rounds, with the total capital raised already eclipsing the entirety of 2025.

　　The report projects China's BCI market could breach the 5-billion-yuan mark in 2026, on track to reach 15 billion yuan by 2030.